Article
Cancer stem cells in neuroblastoma therapy resistance
1 Jan 2019
Abstract excerpt
Neuroblastoma (NB) is the most common cancer of infancy and accounts for nearly one tenth of pediatric cancer deaths. This mortality rate has been attributed to the > 50% frequency of relapse despite intensive, multimodal clinical therapy in patients with progressive NB. Given the disease's heterogeneity and developed resistance, attaining a cure after relapse of progressive NB is highly challenging. A rapid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
